Analysts expect Ptc Therapeutics, Inc. to report revenue of 292.82 M for Q3 26, against a range of 280.37 M to 305.28 M. The most recent reported quarter, Q2 26, came in at 360.52 M, a 14.8% beat against the 314.18 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 196.79 M | 213.17 M | 1.18 B | 178.88 M | 211.01 M | 164.68 M | 272.55 M | 360.52 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 190.14 M | 238.65 M | 193.45 M | 175.92 M | 170.89 M | 317.30 M | 228.13 M | 344.27 M | 305.28 M | 356.90 M | 293.38 M | 326.87 M | 354.89 M | 400.47 M | 487.96 M | 385.19 M | ||||||||||
| Low Estimate | 172.26 M | 212.52 M | 165.55 M | 148.91 M | 153.09 M | 269.18 M | 192.04 M | 284.08 M | 280.37 M | 314.58 M | 270.85 M | 304.37 M | 293.51 M | 345.48 M | 423.76 M | 327.51 M | ||||||||||
| Consensus Estimate | 181.20 M | 225.59 M | 179.50 M | 162.42 M | 161.99 M | 293.24 M | 210.09 M | 314.18 M | 292.82 M | 335.74 M | 282.11 M | 315.62 M | 324.20 M | 372.98 M | 455.86 M | 356.35 M |
Analysts expect Ptc Therapeutics, Inc. to report earnings per share of 0.28 for Q3 26, against a range of 0.27 to 0.29. The most recent reported quarter, Q2 26, came in at 0.92, a 268.0% beat against the 0.25 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.39 | -0.85 | 10.04 | -0.83 | 0.20 | -1.67 | -0.03 | 0.92 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.31 | -0.46 | -0.98 | -0.90 | -1.10 | 0.11 | -0.42 | 0.26 | 0.29 | 0.26 | 0.26 | 0.49 | 0.81 | 0.54 | 1.97 | 0.36 | ||||||||||
| Low Estimate | -1.59 | -0.54 | -1.16 | -1.06 | -1.30 | 0.09 | -0.46 | 0.24 | 0.27 | 0.22 | 0.22 | 0.41 | 0.75 | 0.50 | 1.75 | 0.34 | ||||||||||
| Consensus Estimate | -1.45 | -0.50 | -1.07 | -0.98 | -1.20 | 0.10 | -0.44 | 0.25 | 0.28 | 0.24 | 0.24 | 0.45 | 0.78 | 0.52 | 1.86 | 0.35 |
Pull Wall Street consensus for Ptc Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PTCT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PTCT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PTCT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();